Galmed Pharmaceuticals (GLMD) Operating Margin (2016 - 2018)
Galmed Pharmaceuticals (GLMD) posted quarterly Operating Margin of 954.85% for Q1 2018, down 26306.0% year-over-year from N/an in Q1 2017, and down 21.6% quarter-over-quarter from 1217.91% in Q1 2017.
Galmed Pharmaceuticals (GLMD) Operating Margin (2016 - 2018) Analysis & Trends
Galmed Pharmaceuticals' Operating Margin history runs 3 years deep, the most recent figure standing at 954.85% for Q1 2018.
- In Q1 2018, Operating Margin fell 26306.0% year-over-year to 954.85%; the TTM figure through Jun 2019 stood at 291.64% (changed N/A YoY), while the FY2018 annual figure was 525.76%, up 61378.0% from the prior year.
- Operating Margin for Q1 2018 stood at 954.85%, down from 1217.91% in the prior quarter.
- The five-year high for Operating Margin was 1971.5% in Q3 2016, with the low at 954.85% in Q1 2018.
- The 3-year median for Operating Margin is 1217.91% (2017), against an average of 1381.42%.
- Peak annual rise in Operating Margin reached 26306 bps in 2018, while the deepest fall reached 26306 bps in 2018.
- Galmed Pharmaceuticals' Operating Margin stood at 1971.5% in 2016, then tumbled by 38 bps to 1217.91% in 2017, then decreased by 22 bps to 954.85% in 2018.
- Business Quant data shows GLMD's Operating Margin at 954.85% in Q1 2018, 1217.91% in Q1 2017, and 1971.5% in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 19.75% |
| 10 | Galmed Pharmaceuticals | 2.32 Mn | -9.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 78.67% |
| Mar 31, 2018 | 954.85% |
| Mar 31, 2017 | 1,217.91% |
| Sep 30, 2016 | 1,971.50% |